CHU Nantes-Department of Dentistry
Nantes, 44000, France
Location status: Recruiting
NCT Number: NCT06776640
The number of patients treated in Implantology at Nantes University Hospital is 400 per year. This pilot study aims to demonstrate the efficacy of a 6-month oral cholecalciferol supplementation on osseointegration in patients requiring dental implants and presenting with vitamin D deficiency, compared to French patients who have not undergone vitamin D screening
Interested in participating?
Request Info18 year and older
All sexes
Observational
Nantes, 44000, France
Location status: Recruiting
This study will be conducted on patients with vitamin D deficiency or insufficiency who visit the Restorative and Surgical Dentistry Department at the Dental Care Center of Nantes University Hospital for implant surgery. The investigator will present the study to them and record their verbal non-opposition. Clinical data from before the surgery (approximately 3 months prior), during the surgery, and postoperative visits up to 3 months afterward will be included in the OSIVID study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months (surgery and 3 months after)
The stability of the implant measured by RFA (Resonance Frequency Analysis)
Contact information is provided by the study sponsor or research team.
Alexandra Poinas, PhD
CONTACT
Anne-Gaelle Chaux, MD PhD
CONTACT
Nantes University Hospital
Other
Efficacy of Perioperative Oral Vitamin D3 Supplementation on Implant Osseointegration in Patients With Vitamin D Deficiency
Acronym: OSIVID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06783595
Implant Site Reaction, Mouth Diseases
Loma Linda, California, United States
View Trial DetailsNCT06724107
Implant Site Reaction
Madrid, Spain
View Trial DetailsNCT06590753
Implant Site Reaction
Cairo, Egypt
View Trial DetailsNCT06515886
Bacterial Infections, Bacterial Infections and Mycoses
Montreal, Quebec, Canada
View Trial Details